InsiderTrades.com logo

FDMT Insider Trading

Insider Ownership Percentage: 9.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $109,414.60

4D Molecular Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at 4D Molecular Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

4D Molecular Therapeutics Share Price & Price History

Current Price: $11.19
Price Change: ▲ Price Increase of +0.49 (4.58%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for FDMT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

4D Molecular Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025Scott BizilyInsiderSell1,635$10.59$17,314.653,594View SEC Filing Icon  
10/24/2025Scott BizilyInsiderSell2,678$12.00$32,136.003,594View SEC Filing Icon  
10/16/2025Scott BizilyInsiderSell1,635$10.17$16,627.955,188View SEC Filing Icon  
10/9/2025Scott BizilyInsiderSell2,408$10.00$24,080.005,188View SEC Filing Icon  
9/23/2025Scott BizilyInsiderSell2,407$8.00$19,256.007,596View SEC Filing Icon  
9/16/2024Scott BizilyInsiderSell500$16.33$8,165.006,781View SEC Filing Icon  
7/16/2024Scott BizilyInsiderSell1,750$27.11$47,442.506,781View SEC Filing Icon  
7/11/2024Scott BizilyInsiderSell1,996$25.00$49,900.006,781View SEC Filing Icon  
7/10/2024David KirnCEOSell12,923$22.49$290,638.271,059,153View SEC Filing Icon  
7/1/2024Scott BizilyInsiderSell4,248$21.36$90,737.281,737View SEC Filing Icon  
6/24/2024David KirnCEOSell12,930$23.10$298,683.001,059,153View SEC Filing Icon  
5/16/2024Scott BizilyInsiderSell1,750$25.45$44,537.501,737View SEC Filing Icon  
4/16/2024Scott BizilyInsiderSell1,750$25.74$45,045.001,737View SEC Filing Icon  
4/1/2024Scott BizilyInsiderSell8,153$31.78$259,102.341,737View SEC Filing Icon  
3/27/2024Scott BizilyInsiderSell5,833$35.04$204,388.321,737View SEC Filing Icon  
3/18/2024Scott BizilyInsiderSell1,750$31.27$54,722.501,737View SEC Filing Icon  
2/27/2024Scott BizilyInsiderSell1,909$30.00$57,270.001,737View SEC Filing Icon  
2/16/2024Scott BizilyInsiderSell1,750$27.67$48,422.501,737View SEC Filing Icon  
2/8/2024David KirnCEOSell92,001$27.13$2,495,987.131,059,153View SEC Filing Icon  
2/8/2024Scott BizilyInsiderSell6,244$27.50$171,710.001,737View SEC Filing Icon  
2/5/2024Robert Young KimInsiderSell24,552$30.05$737,787.601,043View SEC Filing Icon  
1/23/2024David KirnCEOSell5,696$18.41$104,863.361,151,154View SEC Filing Icon  
1/4/2024David KirnCEOSell40,732$20.31$827,266.921,185,087View SEC Filing Icon  
1/4/2024Global Investors Lp VikingMajor ShareholderSell540,000$19.53$10,546,200.004,247,914View SEC Filing Icon  
6/8/2023Scott BizilyInsiderSell3,750$20.85$78,187.501,737View SEC Filing Icon  
6/1/2023Scott BizilyInsiderSell2,247$18.31$41,142.571,737View SEC Filing Icon  
5/9/2023Global Investors Lp VikingMajor ShareholderBuy850,000$16.00$13,600,000.004,787,914View SEC Filing Icon  
4/21/2023Jacob ChackoDirectorSell5,000$20.05$100,250.00View SEC Filing Icon  
4/21/2023Scott BizilyInsiderSell3,750$20.00$75,000.002,109View SEC Filing Icon  
3/1/2023Scott BizilyInsiderSell2,248$19.30$43,386.402,109View SEC Filing Icon  
2/21/2023David KirnCEOSell17,997$20.96$377,217.121,875,602View SEC Filing Icon  
1/19/2023David KirnCEOSell10,899$20.03$218,306.971,902,224View SEC Filing Icon  
12/15/2022David KirnCEOSell32,933$23.59$776,889.471,967,067View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for 4D Molecular Therapeutics (NASDAQ:FDMT)

99.27% of 4D Molecular Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FDMT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

4D Molecular Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Armistice Capital LLC1,096,000$9.52M0.1%+265.3%1.918%Search for SEC Filing on Google Icon
11/17/2025Proficio Capital Partners LLC20,121$0.18M0.0%-28.1%0.035%Search for SEC Filing on Google Icon
11/17/2025Wexford Capital LP4,676$41K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC23,000$0.20M0.0%+11.1%0.040%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC200,000$1.74M0.2%N/A0.350%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC1,149,401$9.99M0.0%-22.5%2.012%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.18,900$0.16M0.0%-13.9%0.033%Search for SEC Filing on Google Icon
11/17/2025Decheng Capital LLC92,748$0.81M0.1%-61.3%0.162%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP16,400$0.14M0.0%N/A0.029%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE819,266$7.12M0.0%-9.0%1.434%Search for SEC Filing on Google Icon
11/17/2025ArrowMark Colorado Holdings LLC504,115$4.38M0.1%-2.0%0.882%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC179,075$1.56M0.0%N/A0.313%Search for SEC Filing on Google Icon
11/14/2025Creative Planning37,710$0.33M0.0%N/A0.066%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.471,270$4.10M0.0%+3.5%0.825%Search for SEC Filing on Google Icon
11/14/2025Man Group plc18,488$0.16M0.0%-86.3%0.032%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC16,712$0.15M0.0%N/A0.029%Search for SEC Filing on Google Icon
11/14/2025Brooklyn Investment Group39,586$0.34M0.0%-30.4%0.069%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP273,496$2.38M0.0%-48.5%0.479%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC50,000$0.43M0.0%+100.0%0.088%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC46,837$0.41M0.0%-11.4%0.082%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.11,673$0.10M0.0%-59.1%0.025%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG94,900$0.83M0.0%-1.7%0.203%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets89,624$0.78M0.0%+40.2%0.192%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.3,410$30K0.0%-84.4%0.007%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC93,828$0.82M0.0%-16.1%0.201%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP58,006$0.50M0.0%+3.7%0.124%Search for SEC Filing on Google Icon
11/12/2025DNB Asset Management AS21,639$0.19M0.0%-22.0%0.046%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC18,651$0.16M0.0%-7.2%0.040%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP12,879$0.11M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/10/2025Peapod Lane Capital LLC322,081$2.80M2.5%+1.1%0.690%Search for SEC Filing on Google Icon
11/10/2025Ameritas Investment Partners Inc.3,355$29K0.0%-31.3%0.007%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.8,186$71K0.0%-12.0%0.018%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.2,575,122$22.38M0.0%-5.9%5.514%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.513,515$4.46M0.0%-42.2%1.100%Search for SEC Filing on Google Icon
11/7/2025PNC Financial Services Group Inc.7,306$63K0.0%-20.2%0.016%Search for SEC Filing on Google Icon
11/6/2025Abich Financial Wealth Management LLC9,214$80K0.0%N/A0.020%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers64,179$0.56M0.0%-2.7%0.137%Search for SEC Filing on Google Icon
11/3/2025AlphaQuest LLC15,295$0.13M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/3/2025Impact Partnership Wealth LLC11,078$96K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/3/2025Ballentine Partners LLC16,359$0.14M0.0%N/A0.035%Search for SEC Filing on Google Icon
11/3/2025Federated Hermes Inc.1,594,832$13.86M0.0%-4.3%3.415%Search for SEC Filing on Google Icon
10/30/2025Strs Ohio25,100$0.22M0.0%N/A0.054%Search for SEC Filing on Google Icon
10/29/2025Inscription Capital LLC10,783$94K0.0%N/A0.023%Search for SEC Filing on Google Icon
10/15/2025Harbor Capital Advisors Inc.11,901$0.10M0.0%-52.8%0.025%Search for SEC Filing on Google Icon
10/14/2025Farther Finance Advisors LLC4,952$43K0.0%+117.4%0.011%Search for SEC Filing on Google Icon
10/7/2025Assenagon Asset Management S.A.663,657$5.77M0.0%+2.3%1.421%Search for SEC Filing on Google Icon
8/15/2025Rangeley Capital LLC13,000$48K0.1%N/A0.028%Search for SEC Filing on Google Icon
8/15/2025Man Group plc134,932$0.50M0.0%+159.7%0.289%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP24,015$89K0.0%-67.3%0.051%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets63,914$0.24M0.0%+128.5%0.137%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC25,000$93K0.0%+100.3%0.054%Search for SEC Filing on Google Icon
8/15/2025BVF Inc. IL4,629,289$17.18M0.6%+1.5%9.913%Search for SEC Filing on Google Icon
8/14/2025PDT Partners LLC20,097$75K0.0%-63.5%0.043%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC190,373$0.71M0.0%+35.1%0.411%Search for SEC Filing on Google Icon
8/14/2025Raymond James Financial Inc.455,470$1.69M0.0%+54.7%0.983%Search for SEC Filing on Google Icon
8/14/2025Redmile Group LLC112,168$0.42M0.0%-88.8%0.242%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.21,958$81K0.0%-17.0%0.047%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 14,849$55K0.0%-20.1%0.032%Search for SEC Filing on Google Icon
8/14/2025Sei Investments Co.28,535$0.11M0.0%N/A0.062%Search for SEC Filing on Google Icon
8/14/2025Federated Hermes Inc.1,667,338$6.19M0.0%+33.4%3.599%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP257,620$0.96M0.0%+62.8%0.556%Search for SEC Filing on Google Icon
8/13/2025Decheng Capital LLC239,510$0.89M0.2%-28.6%0.517%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.140,325$0.52M0.0%+19.2%0.303%Search for SEC Filing on Google Icon
8/13/2025Norges Bank54,219$0.20M0.0%N/A0.117%Search for SEC Filing on Google Icon
8/13/2025Quadrature Capital Ltd11,257$42K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/13/2025Russell Investments Group Ltd.21,816$81K0.0%+11.7%0.047%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd78,580$0.29M0.0%N/A0.170%Search for SEC Filing on Google Icon
8/12/2025American Century Companies Inc.48,810$0.18M0.0%+11.5%0.105%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers65,958$0.25M0.0%-6.8%0.142%Search for SEC Filing on Google Icon
8/12/2025Dynamic Technology Lab Private Ltd16,369$61K0.0%+35.6%0.035%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC20,097$75K0.0%-48.8%0.043%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC918,533$3.41M0.0%-4.6%1.983%Search for SEC Filing on Google Icon
8/7/2025Los Angeles Capital Management LLC11,280$42K0.0%N/A0.024%Search for SEC Filing on Google Icon
7/31/2025Peapod Lane Capital LLC318,537$1.18M1.2%+62.6%0.688%Search for SEC Filing on Google Icon
7/30/2025Privium Fund Management B.V.197,458$0.73M0.2%+50.7%0.426%Search for SEC Filing on Google Icon
7/9/2025Harbor Capital Advisors Inc.25,211$94K0.0%-17.6%0.054%Search for SEC Filing on Google Icon
7/1/2025Kera Capital Partners Inc.24,068$89K0.0%N/A0.052%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC400,606$1.29M0.0%+1,103.4%0.865%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC140,879$0.46M0.0%-33.2%0.304%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.4,168,394$13.46M0.0%-2.5%8.997%Search for SEC Filing on Google Icon
5/16/2025Dynamic Technology Lab Private Ltd12,074$39K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/16/2025Millennium Management LLC1,633,987$5.28M0.0%+15.0%3.527%Search for SEC Filing on Google Icon
5/16/2025BVF Inc. IL4,561,289$14.73M0.6%+70.8%9.846%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC14,340$46K0.0%N/A0.031%Search for SEC Filing on Google Icon
5/15/2025Redmile Group LLC997,235$3.22M0.3%-16.7%2.153%Search for SEC Filing on Google Icon
5/15/2025PDT Partners LLC54,999$0.18M0.0%-9.7%0.119%Search for SEC Filing on Google Icon
5/15/2025Cubist Systematic Strategies LLC84,172$0.27M0.0%-81.2%0.182%Search for SEC Filing on Google Icon
5/14/2025MetLife Investment Management LLC28,745$93K0.0%-18.8%0.062%Search for SEC Filing on Google Icon
5/14/2025Hsbc Holdings PLC52,171$0.17M0.0%+51.6%0.113%Search for SEC Filing on Google Icon
5/14/2025Wellington Management Group LLP247,471$0.80M0.0%+39.6%0.534%Search for SEC Filing on Google Icon
5/13/2025American Century Companies Inc.43,784$0.14M0.0%+12.9%0.095%Search for SEC Filing on Google Icon
5/13/2025Russell Investments Group Ltd.19,532$63K0.0%N/A0.042%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC150,314$0.49M0.0%N/A0.324%Search for SEC Filing on Google Icon
5/12/2025Invesco Ltd.117,768$0.38M0.0%+318.3%0.254%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG236,157$0.76M0.0%-2.4%0.510%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.282,781$0.91M0.0%-8.4%0.610%Search for SEC Filing on Google Icon
5/9/2025Privium Fund Management B.V.131,000$0.42M0.1%+8.3%0.283%Search for SEC Filing on Google Icon
5/8/2025Decheng Capital LLC335,515$1.08M0.3%-16.1%0.724%Search for SEC Filing on Google Icon
5/8/2025Federated Hermes Inc.1,250,181$4.04M0.0%+33,131.8%2.699%Search for SEC Filing on Google Icon
5/6/2025Proficio Capital Partners LLC25,195$75K0.0%+26.0%0.054%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
4D Molecular Therapeutics logo
4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platform in the Netherland and the United States. The company develops a portfolio of genetic medicine product candidates focuses in three therapeutic areas for ophthalmology, cardiology, and pulmonology. Its product pipeline includes 4D-150, which is in phase 1/2 clinical trial for the treatment of wet age-related macular degeneration; and is in phase 1/2 clinical trial for the treatment of diabetic macular edema. The company develops 4D-125, which is in phase 1/2 clinical trial for the treatment of x-linked retinitis pigmentosa; 4D-110, which is in phase 1/2 clinical trial for the treatment of choroideremia; 4D-710, which is in phase 1/2 clinical trial for the treatment cystic fibrosis lung disease; and 4D-310 to treat fabry disease cardiomyopathy and is in phase 1/2 clinical trial. In addition, its product candidates comprises 4D-175, which is in pre-clinical development for the treatment for geographic trophy; and 4D-725 to treat alpha-1 antitrypsin deficiency lung disease and is in pre-clinical development. The company has collaboration and licensing agreements with Arbor Biotechnologies, Inc.; Astellas Gene Therapies, Inc; uniQure biopharma B.V.; and Cystic Fibrosis Foundation. 4D Molecular Therapeutics, Inc. was founded in 2013 and is headquartered in Emeryville, California.
Read More on 4D Molecular Therapeutics

Today's Range

Now: $11.19
Low: $10.54
High: $11.40

50 Day Range

MA: $10.33
Low: $8.32
High: $12.27

52 Week Range

Now: $11.19
Low: $2.23
High: $12.34

Volume

699,100 shs

Average Volume

880,009 shs

Market Capitalization

$639.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.96

Who are the company insiders with the largest holdings of 4D Molecular Therapeutics?

4D Molecular Therapeutics' top insider shareholders include:
  1. Global Investors Lp Viking (Major Shareholder)
  2. David Kirn (CEO)
  3. Scott Bizily (Insider)
  4. Robert Young Kim (Insider)
Learn More about top insider investors at 4D Molecular Therapeutics.

Who are the major institutional investors of 4D Molecular Therapeutics?

4D Molecular Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 5.51%
  2. Federated Hermes Inc. — 3.42%
  3. Millennium Management LLC — 2.01%
  4. Armistice Capital LLC — 1.92%
  5. Bank of America Corp DE — 1.43%
  6. Assenagon Asset Management S.A. — 1.42%
Learn More about top institutional investors of 4D Molecular Therapeutics stock.

Which institutional investors are selling 4D Molecular Therapeutics stock?

During the previous quarter, FDMT stock was sold by these institutional investors:
  1. JPMorgan Chase & Co.
  2. Millennium Management LLC
  3. Two Sigma Investments LP
  4. Vanguard Group Inc.
  5. Decheng Capital LLC
  6. Man Group plc
  7. Bank of America Corp DE
  8. Federated Hermes Inc.

Which institutional investors are buying 4D Molecular Therapeutics stock?

Within the last quarter, FDMT stock was acquired by institutional investors including:
  1. Armistice Capital LLC
  2. Parkman Healthcare Partners LLC
  3. Schonfeld Strategic Advisors LLC
  4. Creative Planning
  5. BNP Paribas Financial Markets
  6. Strs Ohio
  7. Bridgeway Capital Management LLC
  8. ADAR1 Capital Management LLC